360 studies found for:    Open Studies | "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
21 Recruiting A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin aspart (FIAsp);   Drug: insulin aspart
22 Recruiting A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: BioChaperone® Combo;   Drug: Humalog® Mix25
23 Recruiting REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Metformin;   Drug: Placebo
24 Recruiting A Study of LY2605541 and Glargine on Fats in Participants With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: LY2605541;   Biological: Insulin Glargine
25 Recruiting Liraglutide in Newly Onset Type 1 Diabetes.
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Liraglutide
26 Recruiting The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: liraglutide;   Drug: placebo
27 Recruiting A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec;   Drug: insulin glargine;   Drug: insulin aspart
28 Not yet recruiting Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
29 Recruiting A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec/insulin aspart;   Drug: insulin aspart;   Drug: insulin detemir
30 Unknown  A Study Designed to Compare 2 Formulations of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Technosphere Insulin A;   Drug: Technosphere Insulin B;   Drug: Humalog
31 Not yet recruiting A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP);   Drug: Placebo
32 Recruiting Liraglutide as add-on to Insulin in Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Liraglutide;   Drug: Placebo
33 Recruiting AbATE Follow-Up Study
Condition: Diabetes Mellitus, Type 1
Intervention:
34 Recruiting Beta Cell Function in (Pre)Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Glucose;   Device: Continuous glucose monitoring
35 Recruiting Sitagliptin Dose Determination Study
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Sitagliptin
36 Recruiting Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Conditions: Type 1 Diabetes;   Eating Disorder
Intervention:
37 Not yet recruiting Closing the Loop 24/7 in Adolescents With Type 1 Diabetes
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Device: Closed-loop system;   Device: real-time CGM
38 Recruiting Type 1 Diabetes Recurrence in Pancreas Transplants
Condition: Diabetes Mellitus, Type 1
Intervention:
39 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
40 Unknown  Parental Management of Young Children's Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Parental Support;   Behavioral: Diabetes Education

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years